Linlin Qu Selected Research

ginsenoside Rk3

5/2023	Ginsenoside Rk3 is a novel PI3K/AKT-targeting therapeutics agent that regulates autophagy and apoptosis in hepatocellular carcinoma.
10/2021	Hepatoprotective effects of ginsenoside Rk3 in acetaminophen-induced liver injury in mice by activation of autophagy.
9/2021	Ginsenoside Rk3 Suppresses Hepatocellular Carcinoma Development through Targeting the Gut-Liver Axis.
4/2019	Protective effects of ginsenoside Rk3 against chronic alcohol-induced liver injury in mice through inhibition of inflammation, oxidative stress, and apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Linlin Qu Research Topics

Disease

11	Neoplasms (Cancer) 03/2024 - 01/2017
6	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 01/2019
4	Infections 01/2023 - 01/2019
3	Inflammation (Inflammations) 06/2023 - 04/2019
3	Neoplasm Metastasis (Metastasis) 01/2023 - 11/2017
2	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2023 - 01/2023
2	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2018
2	Lung Neoplasms (Lung Cancer) 01/2023 - 06/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 03/2024
1	Liver Neoplasms (Liver Cancer) 03/2024
1	Fibrosis (Cirrhosis) 03/2024
1	Neurothekeoma 08/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 06/2023
1	Obesity 06/2023
1	Stomach Ulcer (Gastric Ulcer) 06/2023
1	Hepatitis B 01/2023
1	Intestinal Fistula 01/2023
1	Acid-Base Imbalance 01/2023
1	Fistula 01/2023
1	Malnutrition (Nutritional Deficiencies) 01/2023
1	Hypoxia (Hypoxemia) 06/2022
1	Endometrial Neoplasms (Endometrial Cancer) 01/2022
1	Gallbladder Neoplasms (Gallbladder Cancer) 01/2022
1	Chemical and Drug Induced Liver Injury 10/2021
1	Acute Liver Failure (Fulminant Hepatic Failure) 10/2021
1	Colorectal Neoplasms (Colorectal Cancer) 03/2021
1	Adenocarcinoma of Lung 01/2020
1	Esophageal Neoplasms (Esophageal Cancer) 01/2020
1	Carcinogenesis 01/2020
1	Fever (Fevers) 07/2019
1	Abdominal Pain (Pain, Abdominal) 07/2019
1	Stomach Neoplasms (Stomach Cancer) 05/2017

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 08/2023 - 05/2016
4	ginsenoside Rh4IBA 06/2023 - 01/2018
4	ginsenoside Rk3IBA 05/2023 - 04/2019
3	ginsenoside Rk1IBA 03/2024 - 01/2020
3	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2017
2	Transcription Factors (Transcription Factor)IBA 08/2023 - 01/2023
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2022
2	GinsenosidesIBA 06/2022 - 04/2022
2	CytokinesIBA 10/2021 - 04/2010
2	Phosphotransferases (Kinase)IBA 12/2017 - 05/2017
1	SaponinsIBA 03/2024
1	Carbon Tetrachloride (Tetrachloromethane)IBA 03/2024
1	protopanaxadiolIBA 03/2024
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 03/2024
1	Interleukin-6 (Interleukin 6)IBA 06/2023
1	Ethanol (Ethyl Alcohol)IBA 06/2023
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 06/2023
1	Glutathione (Reduced Glutathione)IBA 06/2023
1	Mitogen-Activated Protein KinasesIBA 06/2023
1	fas Receptor (CD95 Antigen)IBA 06/2023
1	Malondialdehyde (Propanedial)IBA 06/2023
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2023
1	ProstaglandinsIBA 06/2023
1	Superoxide DismutaseIBA 06/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2023
1	Anti-Idiotypic AntibodiesIBA 01/2023
1	Hepatitis B Core AntigensIBA 01/2023
1	STAT Transcription FactorsIBA 01/2023
1	Histone Deacetylase 2IBA 01/2023
1	CaspasesIBA 01/2023
1	VaccinesIBA 01/2023
1	PowdersIBA 01/2023
1	Thrombin FDA Link 01/2023
1	ElectrolytesIBA 01/2023
1	Diatrizoate Meglumine (Gastrograffin)FDA LinkGeneric 01/2023
1	U 0126 (UO 126)IBA 06/2022
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 06/2022
1	ginsenoside Rh3IBA 06/2022
1	Small Interfering RNA (siRNA)IBA 06/2022
1	Glutamine (L-Glutamine)FDA Link 04/2022
1	Gemcitabine FDA Link 01/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022
1	apatinibIBA 01/2022
1	AntioxidantsIBA 10/2021
1	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2021
1	Fluorouracil (Carac)FDA LinkGeneric 03/2021
1	Long Noncoding RNAIBA 03/2021
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 07/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2019
1	Mesalamine (Mesalazine)FDA LinkGeneric 07/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Transcription Factor 3IBA 01/2019
1	Antiviral Agents (Antivirals)IBA 01/2019
1	Core Binding Factors (Core-Binding Factor)IBA 01/2019
1	tyrosine receptor (receptor, tyrosine)IBA 12/2017
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 05/2017

Therapy/Procedure

6	Therapeutics 05/2023 - 01/2019
2	Hematopoietic Stem Cell Transplantation 08/2023 - 01/2023
1	Adjuvant Chemotherapy 01/2022
1	Drug Therapy (Chemotherapy) 01/2020
1	Intravenous Infusions 07/2019
1	Laparotomy 07/2019
1	Nutritional Support (Artificial Feeding) 07/2019
1	Hepatectomy 01/2019
1	Thymectomy 11/2017